Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

Description

MIM Fertility is committed to improving the success rates of in vitro fertilization by leveraging artificial intelligence (AI) and data analytics. Our focus has been on creating AI solutions that empower IVF clinics to help patients realize their dreams of parenthood. We strive to redefine fertility care standards, aiming to transform the journey of infertility and ensure greater access to fertility solutions globally. Among our innovative offerings are AI-driven software platforms such as EMBRYOAID and FOLLISCAN. EMBRYOAID aids embryologists and physicians by quickly assessing the most promising embryos using images and time-lapse technology, which improves the embryo selection process for IVF. Meanwhile, FOLLISCAN serves as an ovarian follicular monitoring tool that effectively counts and measures follicles of varying sizes through 2D or 3D cine-loops of the ovaries, streamlining imaging ultrasonography workflows to boost diagnostic precision. By integrating advanced technology into fertility treatments, we believe we can significantly enhance patient experiences and outcomes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Cleerly

Country

United States

Website

cleerlyhealth.com

Vendor Details

Company Name

MIM Fertility

Founded

2015

Country

Poland

Website

www.mimfertility.ai/

Product Features

Product Features

Alternatives

Alternatives

Join AI Reviews

Join AI

Miracle Advance Technologies